Related Experiment Videos
Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells
Abstract:
Participation of growth factors and intracellular cAMP in direct antiproliferative action of interferon alpha (IFN-alpha) was investigated in PC-3 human prostate carcinoma cell line. IFN-alpha inhibited proliferation of PC-3 cells in a dose-dependent manner in vitro, and the effect was reversible. Fibroblast growth factor, epidermal growth factor and platelet-derived growth factor, when added to the culture medium, showed no effect on growth of PC-3 cells in presence or absence of IFN-alpha. Transforming growth factor beta (TGF-beta) significantly inhibited PC-3 cell growth, and the effect was additived to that of IFN-alpha. TGF-beta content in conditioned medium of PC-3 cells was not affected by treatment with IFN-alpha. On the other hand, IFN-alpha increased intracellular cAMP concentration about 20-fold. Dibutyryl cAMP and reagents which elevated intracellular cAMP level also inhibited PC-3 cell growth. These indicated that direct antiproliferative effect of IFN-alpha on PC-3 cells was at least partly mediated by cAMP, and that neither growth factors nor a growth inhibitor participated in the action of IFN-alpha.
Insights
Interferon alpha (IFN-alpha) inhibits prostate cancer cell growth partly through increased intracellular cAMP. Other growth factors did not influence this antiproliferative effect.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Interferon alpha (IFN-alpha) is a cytokine with known antiproliferative properties.
- The precise mechanisms underlying IFN-alpha's direct antiproliferative action, particularly in prostate cancer, require further elucidation.
- The role of growth factors and intracellular signaling molecules like cAMP in IFN-alpha's effects is not fully understood.
Purpose of the Study:
- To investigate the involvement of growth factors and intracellular cyclic adenosine monophosphate (cAMP) in the direct antiproliferative action of interferon alpha (IFN-alpha).
- To determine the effect of IFN-alpha on PC-3 human prostate carcinoma cell proliferation in vitro.
- To explore the potential mediation of IFN-alpha's antiproliferative effects by cAMP and specific growth factors.
Main Methods:
- PC-3 human prostate carcinoma cells were cultured in vitro.
- Cells were treated with varying concentrations of IFN-alpha.
- The effects of fibroblast growth factor, epidermal growth factor, platelet-derived growth factor, and transforming growth factor beta (TGF-beta) on cell proliferation were assessed in the presence and absence of IFN-alpha.
- Intracellular cAMP levels were measured following IFN-alpha treatment.
- The impact of exogenous dibutyryl cAMP and other cAMP-elevating reagents on cell growth was evaluated.
Main Results:
- IFN-alpha demonstrated a dose-dependent and reversible inhibition of PC-3 cell proliferation.
- Fibroblast growth factor, epidermal growth factor, and platelet-derived growth factor did not affect PC-3 cell growth, with or without IFN-alpha.
- Transforming growth factor beta (TGF-beta) significantly inhibited cell growth, with an additive effect when combined with IFN-alpha.
- IFN-alpha treatment led to a substantial (approximately 20-fold) increase in intracellular cAMP concentration.
- Dibutyryl cAMP and other cAMP-elevating agents also inhibited PC-3 cell growth.
Conclusions:
- The direct antiproliferative effect of IFN-alpha on PC-3 prostate carcinoma cells is, at least partly, mediated by an increase in intracellular cAMP.
- Growth factors and growth inhibitors do not appear to play a significant role in the direct antiproliferative action of IFN-alpha on this cell line.
- These findings highlight the importance of the cAMP signaling pathway in mediating the anti-cancer effects of IFN-alpha in prostate cancer.